Immunoscore® is an in vitro diagnostic test predicting the risk of relapse in early stage colon cancer patients, by measuring the host immune response at the tumor site. This test can be ordered by oncologists for their patients for a better disease management.
Immunoscore ® IC is an assay for the detection of PD-L1 protein and the concomitant detection of CD8 + cells in Non-Small Cell Lung cancer (NSCLC) tissue.
HalioDx Inc. | 737N 5th Street | Richmond | Virginia 23219 |USA
HalioDx | Luminy Biotech Entreprises 163 Avenue de Luminy | 13288 Marseille Cedex 9 | FRANCE